Journal article

Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103)

Kristina Lindemann, Philip J Beale, Emma Rossi, Jeff C Goh, Michelle M Vaughan, Meaghan E Tenney, Julie K Martyn, Dirkje Sommeijer, Jose L Iglesias, Gabriel Kremmidiotis, Jeremy Simpson, Elizabeth Doolin, Tina C Lavranos, Annabell Leske, Anneso S Veillard, David Espinoza, Martin R Stockler, Danny Rischin

Cancer Chemotherapy and Pharmacology | SPRINGER | Published : 2019